350 related articles for article (PubMed ID: 6862346)
1. [Current therapy: combined drug therapy of hyperuricemia, gout and alcohol induced fatty liver].
Mertz DP
Fortschr Med; 1983 May; 101(18):851-3. PubMed ID: 6862346
[No Abstract] [Full Text] [Related]
2. [Treatment of hyperuricaemia with a combination of allopurinol and benzbromaron (author's transl)].
Matzkies F; Berg G
Dtsch Med Wochenschr; 1976 Oct; 101(43):1568-70. PubMed ID: 991731
[TBL] [Abstract][Full Text] [Related]
3. [Allomaron in hyperuricemia and gout].
Barsom S
ZFA (Stuttgart); 1979 Aug; 55(24):1336-40. PubMed ID: 539082
[No Abstract] [Full Text] [Related]
4. [Therapy of hyperuricemia and gout. Effect of a combination therapy of allopurinol with benzbromarone].
Matzkies F
Fortschr Med; 1983 May; 101(20):953-9. PubMed ID: 6873850
[No Abstract] [Full Text] [Related]
5. [Reducing the risks in the treatment of gout and hyperuricaemia (author's transl)].
Mertz DP
Dtsch Med Wochenschr; 1976 Aug; 101(35):1288-92. PubMed ID: 782809
[No Abstract] [Full Text] [Related]
6. [Isolated or combined drug therapy of hyperuricemia?].
Mertz DP
Dtsch Med Wochenschr; 1977 Jul; 102(30):1096-7. PubMed ID: 891391
[No Abstract] [Full Text] [Related]
7. [Clearance of oxypurines in normal subjects and in gout patients subjected to a purine-free diet. Effects of allopurinol].
Porcelli B; Pizzichini M; Di Stefano A; Leoncini R; Taddeo A; Marinello E
Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1105-10. PubMed ID: 2629828
[TBL] [Abstract][Full Text] [Related]
8. [Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].
Matzkies F; Neuwirth R; Berg G
Fortschr Med; 1976 Sep; 94(26):1427-9. PubMed ID: 976920
[TBL] [Abstract][Full Text] [Related]
9. [The effect on uric acid and other laboratory parameters. A long-term study].
Dorn M
ZFA (Stuttgart); 1982 Feb; 58(5):296-300. PubMed ID: 7043937
[No Abstract] [Full Text] [Related]
10. [Effect of uric acid lowering drugs in low dosage in patients with hyperuricemia and hypertriglyceridemia in a randomized group study].
Arntz HR; Dreykluft HR; Leonhardt H
Fortschr Med; 1979 Jul; 97(27):1212-4. PubMed ID: 457017
[TBL] [Abstract][Full Text] [Related]
11. [Long lasting normalization of uric acid after combination therapy with 300 mg allopurinol and 60 mg benzbromarone in patients with gout and hyperuricemia].
Matzkies F
Med Klin (Munich); 1992 Sep; 87(9):460-2. PubMed ID: 1406482
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of uric acid and oxypurines in normal subjects and in gout patients].
Porcelli B; Pizzichini M; Di Stefano A; Leoncini R; Taddeo A; Marinello E
Boll Soc Ital Biol Sper; 1989 Dec; 65(12):1201-5. PubMed ID: 2627336
[TBL] [Abstract][Full Text] [Related]
13. [Excretion and serum concentrations of allopurinol, oxipurinol and oxipurines in combined treatment with allopurinol and benzbromarone in increasing doses].
Mertz DP; Borner K
Med Welt; 1983 Sep; 34(36):974-9. PubMed ID: 6633222
[No Abstract] [Full Text] [Related]
14. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
[TBL] [Abstract][Full Text] [Related]
15. [Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)].
Mertz DP
Med Klin; 1977 Apr; 72(15):664-8. PubMed ID: 857138
[TBL] [Abstract][Full Text] [Related]
16. [The use of Allomaron in treating hyperuricemia].
Balkarov IM
Ter Arkh; 1994; 66(1):40-2. PubMed ID: 8146793
[No Abstract] [Full Text] [Related]
17. [Long-term therapy with benzbromarone in uric arthritis].
Bröll H; Sochor H; Tausch G; Eberl R
Wien Med Wochenschr; 1975 Sep; 125(28):546-8. PubMed ID: 816095
[No Abstract] [Full Text] [Related]
18. [Hyperuricemia and gout--treatment].
Gröbner W; Walter-Sack I
Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
[No Abstract] [Full Text] [Related]
19. [The effect of benzbromaron in gout patients with limited kidney function].
Kuzmits R; Bresnik W; Müller MM
Fortschr Med; 1979 Nov; 97(44):2057-61. PubMed ID: 511087
[TBL] [Abstract][Full Text] [Related]
20. [Hyperuricemia due to hypoxanthine-guanine-phosphoribosyltransferase deficiency].
Blétry O; Cartier P; Hamet M; Clauvel JP
Nouv Presse Med; 1974 Apr; 3(16):995-9. PubMed ID: 4836472
[No Abstract] [Full Text] [Related]
[Next] [New Search]
